Gaithersburg key facts
Employees in Gaithersburg
>1 billion USD
Research and development annual spend
>10,000 square feet
Employee fitness center
Our team of world-renowned scientists collaborate to support the identification and validation of targets regulating biological processes which are the fundamental drivers of human disease. Using a variety of tools, including in vivo and in vitro assays and bio-informatic approaches, our scientists rigorously test biological hypotheses across our focus areas.
Our Antibody Discovery and Protein Engineering Department applies cutting-edge technologies in the discovery of novel therapeutic biologics to change the lives of patients. The team works collaboratively across all therapy areas and deploys a plethora of innovative in-house platform technologies such as phage and ribosome display, Fc engineering, and novel peptide discovery methodologies. We have an exceptional track record of delivery, having discovered and engineered approaching 100 protein therapeutics that have entered the clinic.
Our translational expertise enables us to accelerate drug development in human disease by selecting the right patients in early clinical trials. We accomplish this by embedding human target validation earlier in research, utilising innovative clinical trial design approaches and integrating multiple, relevant scientific insights across our focus areas.
As a leader in personalised healthcare, we are committed to matching new medicines to the patient most in need. We combine industry-leading expertise in companion diagnostics with laboratory science in molecular diagnostics, tissue diagnostics, imaging and protein biomarkers, and we work collaboratively with our external partners to harness breakthrough technologies across the life-cycle of our medicines.
Our Biopharmaceutical Development team develops the process and analytics to produce and characterise product candidates, including the formulations and drug product forms, for delivering medicines to patients. Working closely with research, the team helps define and select the best product candidates to progress into development.
Our Early Clinical Development team designs and delivers early phase development strategies and exploratory studies that build the credentials of novel targets. Clinical Operations delivers global clinical trials for late stage projects across our pipeline, using both internal and external programme and study management expertise. Our teams are especially experienced in cardiovascular and respiratory diseases and in managing large outcome studies in partnership with Academic Research Organisations.
"We overcame the challenges and put the antibody to the test in human clinical trials and it worked perfectly. It's like a Eureka! moment. Not many people can have that type of experience."
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.